Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Clinical Characteristics and Outcomes of Splenic Infarction in Cancer Patients - a Retrospective, Single Center Report of 206 Cases

Jan Philipp Bewersdorf, MD, Nishita Parmar, MD, Scott Gettinger, MD, Gary Israel, MD, Alfred Ian Lee, MD PhD

Blood (2020) 136 (Supplement 1): 22–23.

https://doi.org/10.1182/blood-2020-136646

Published: 2020

Journal Articles

Advanced Imaging and Targeted Myeloma Lesion Biopsies to Enhance Global Response Assessment and Evaluate Spatial Heterogeneity in Multiple Myeloma

Sabrina L. Browning, MD, Terri L. Parker, MD, Noffar Bar, MD, Tara Anderson, PA, Madhav V. Dhodapkar, MBBS, Stuart Seropian, MD, Alfred Ian Lee, MD PhD, Thomas Prebet, MD PhD, Stephanie Halene, MD, Mina L. Xu, MD, Elan Gorshein, DO, JD, MPH, Ashita Talsania, MCRP, MBBS, Wajih Zaheer Kidwai, MD, David H. Witt, MD, Victor Chang, MD, Andrew Lischuk, MD, Wei Wei, MD PhD, Andrew Haims, MD, Natalia Neparidze, MD

Blood (2020) 136 (Supplement 1): 20–22.

https://doi.org/10.1182/blood-2020-136478

Published: 2020

Journal Articles

Factors Associated with Burnout Among Hematology & Oncology Physicians

Leah E Masselink, PhD, Alfred Ian Lee, MD PhD, Clese E Erikson, MPAff

Blood (2020) 136 (Supplement 1): 41–42.

https://doi.org/10.1182/blood-2020-139798

Published: 2020

Journal Articles

Admission Rothman Index, Aspirin, and Intermediate Dose Anticoagulation Effects on Outcomes in COVID-19: A Multi-Site Propensity Matched Analysis

George Goshua, MD, Yiwen Liu, Matthew L. Meizlish, MSc, Rebecca Fine, MD, Kejal Amin, PharmD, Eric Chang, MD, Yuxin Liu, MD, Dayna McManus, PharmD, Adina Petrosan, PharmD, Cassius Ilya Ochoa Chaar, MD, Hyung J. Chun, MD, Nicholas A. Defilippo, PharmD, Donna S. Neuberg, ScD, Kent A. Owusu, PharmD, Alfred Ian Lee, MD PhD

Blood (2020) 136 (Supplement 1): 23–24.

https://doi.org/10.1182/blood-2020-143349

Published: 2020

Journal Articles

Cost Effectiveness of Caplacizumab in Acquired Thrombotic Thrombocytopenic Purpura

George Goshua, MD, Pranay Sinha, MD, Jeanne E. Hendrickson, MD, Christopher A. Tormey, MD, Pavan Bendapudi, MD, Alfred Ian Lee, MD PhD

Blood (2020) 136 (Supplement 1): 18–19.

https://doi.org/10.1182/blood-2020-138515

Published: 2020

Journal Articles

Measuring the Impact of COVID-19 on Hematology-Oncology Trainees: A Quantitative and Qualitative Assessment

Urshila Durani, Ana I. Velazquez Manana, MDMSc, Jori May, MD, Marquita Nelson, MD, Ze Zheng, MBBS,PhD, Anurekha Gollapudi, MD, Sara Taveras Alam, MD, Robby Reynolds, MPA, John Colton Thompson, Ashok Kumbamu, PhD, Devika G. Das, MD, Martina C. Murphy, MD, Elizabeth Henry, MD, Alfred Ian Lee, MD PhD, Ariela L. Marshall, MD, Ted Wun, MD, Lachelle Weeks, MD PhD

Blood (2020) 136 (Supplement 1): 20–21.

https://doi.org/10.1182/blood-2020-143347

Published: 2020

Journal Articles

VWF/ADAMTS13 Ratios Are Potential Markers of Immunothrombotic Complications in Patients with COVID-19: A Cross-Sectional Study

Daria V Madeeva, MD, Jana Christian, MD, George Goshua, MD, Hyung J. Chun, MD, Alfred Ian Lee, MD PhD, Alexander B Pine, MDPhD

Blood (2020) 136 (Supplement 1): 34–35.

https://doi.org/10.1182/blood-2020-142917

Published: 2020

Journal Articles

The Impact of COVID-19 on Hematology-Oncology Fellowship Programs: Program Director Perspectives

Ana I. Velazquez Manana, MDMSc, Urshila Durani, MDMPH, Robby Reynolds, MPA, Ashok Kumbamu, PhD, Devika G. Das, MD, Martina C. Murphy, MD, Elizabeth Henry, MD, Alfred Ian Lee, MD PhD, Ariela L. Marshall, MD

Blood (2020) 136 (Supplement 1): 24–25.

https://doi.org/10.1182/blood-2020-141514

Published: 2020

Journal Articles

Whole Exome Sequencing and Extended Thrombophilia Testing in Patients with Venous Thromboembolism

Blood (2018) 132 (Supplement 1): 2506.

https://doi.org/10.1182/blood-2018-99-115529

Published: 2018

Journal Articles

Cost Effectiveness of Rituximab As Adjunctive Therapy in Reducing Apheresis Procedures and Hospital Length of Stay in Relapsed Thrombotic Thrombocytopenic Purpura

George Goshua, MD, Amit Gokhale, MD, Jeanne E. Hendrickson, MD, Christopher Tormey, MD, Alfred Ian Lee, MD PhD

Blood (2018) 132 (Supplement 1): 3814.

https://doi.org/10.1182/blood-2018-99-113621

Published: 2018

Journal Articles

Venous Thromboembolism (VTE) Education Preferences Amongst Physicians and Patients: A Qualitative Needs Assessment

Prerak V Juthani, BA, Danya Muneer Ahmed, Osama Muneer Ahmed, BA, BS, Robert D. Bona, MD, Natalia Neparidze, MD, Alfred Ian Lee, MD PhD

Blood (2018) 132 (Supplement 1): 5810.

https://doi.org/10.1182/blood-2018-99-119418

Published: 2018

Journal Articles

Impact of a Pharmacist Driven Anti-Xa Level Monitoring Protocol on Therapeutic Drug Monitoring Practice Patterns

Muhammad Effendi, PharmD, Martha Stutsky, PharmD, Caleigh A. Curran, PharmD, Kent A. Owusu, PharmD, Alfred Ian Lee, MD PhD

Blood (2018) 132 (Supplement 1): 2284.

https://doi.org/10.1182/blood-2018-99-119379

Published: 2018

Journal Articles

Using the Rothman Index to Predict Discharge and Readmission Rates in an Inpatient Hematology Unit

Roger Y. Kim, BS, Xiaopan Yao, PhD, Peter Longley, RN, DNP, Joan Rimar, DNSc, RN, Chryssanthi Kournioti, MD, Alfred Ian Lee, MD PhD

Blood (2014) 124 (21): 1302.

https://doi.org/10.1182/blood.V124.21.1302.1302

Published: 2014

Journal Articles

Heparin-Induced Thrombocytopenia and Cardiac Surgery: A Role for Hematologists in Critical Care Units

Alfred Ian Lee, MD, PhD, Katelyn W. Sylvester, PharmD, James Rawn, MD, John Fanikos, RPh, Nancy Berliner, MD

Blood (2011) 118 (21): 2062.

https://doi.org/10.1182/blood.V118.21.2062.2062

Published: 2011

Journal Articles

Clinical Significance of Coagulation Studies in Predicting Response to Recombinant Factor VIIa in Cardiac Surgery Patients

Alfred Ian Lee, MD, PhD, Federico Campigotto, MS, James Rawn, MD, Donna Neuberg, ScD, Richard M. Kaufman, MD, Nancy Berliner, MD

Blood (2011) 118 (21): 4351.

https://doi.org/10.1182/blood.V118.21.4351.4351

Published: 2011

Journal Articles

Treatment Choice and Outcome In Diffuse Large B Cell Lymphoma (DLBCL) Patients 75 Years and Older

Christiana E. Toomey, Alona Muzikanksy, MA, Alfred Ian Lee, MD, PhD, Jeffrey A. Barnes, MD, PhD, James S. Michaelson, PhD, Jeremy S. Abramson, MD, Ephraim P. Hochberg, MD

Blood (2010) 116 (21): 733.

https://doi.org/10.1182/blood.V116.21.733.733

Published: 2010

Journal Articles

Rituximab Does Not Improve Progression Free (PFS) or Overall Survival (OS) in Patients with Limited Stage Diffuse Large B Cell Lymphoma (DLBCL).

Ephraim P. Hochberg, MD, Nicole Birrer, Christiana E. Toomey, Jeffrey A. Barnes, M.D., Alfred Ian Lee, MD, Ann LaCasce, MD, Jeremy S. Abramson, MD

Blood (2009) 114 (22): 3755.

https://doi.org/10.1182/blood.V114.22.3755.3755

Published: 2009

NARROW

Clinical Characteristics and Outcomes of Splenic Infarction in Cancer Patients - a Retrospective, Single Center Report of 206 Cases

Advanced Imaging and Targeted Myeloma Lesion Biopsies to Enhance Global Response Assessment and Evaluate Spatial Heterogeneity in Multiple Myeloma

Factors Associated with Burnout Among Hematology & Oncology Physicians

Admission Rothman Index, Aspirin, and Intermediate Dose Anticoagulation Effects on Outcomes in COVID-19: A Multi-Site Propensity Matched Analysis

Cost Effectiveness of Caplacizumab in Acquired Thrombotic Thrombocytopenic Purpura

Measuring the Impact of COVID-19 on Hematology-Oncology Trainees: A Quantitative and Qualitative Assessment

VWF/ADAMTS13 Ratios Are Potential Markers of Immunothrombotic Complications in Patients with COVID-19: A Cross-Sectional Study

The Impact of COVID-19 on Hematology-Oncology Fellowship Programs: Program Director Perspectives

Whole Exome Sequencing and Extended Thrombophilia Testing in Patients with Venous Thromboembolism

Cost Effectiveness of Rituximab As Adjunctive Therapy in Reducing Apheresis Procedures and Hospital Length of Stay in Relapsed Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism (VTE) Education Preferences Amongst Physicians and Patients: A Qualitative Needs Assessment

Impact of a Pharmacist Driven Anti-Xa Level Monitoring Protocol on Therapeutic Drug Monitoring Practice Patterns

Using the Rothman Index to Predict Discharge and Readmission Rates in an Inpatient Hematology Unit

Heparin-Induced Thrombocytopenia and Cardiac Surgery: A Role for Hematologists in Critical Care Units

Clinical Significance of Coagulation Studies in Predicting Response to Recombinant Factor VIIa in Cardiac Surgery Patients

Treatment Choice and Outcome In Diffuse Large B Cell Lymphoma (DLBCL) Patients 75 Years and Older

Rituximab Does Not Improve Progression Free (PFS) or Overall Survival (OS) in Patients with Limited Stage Diffuse Large B Cell Lymphoma (DLBCL).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only